XML 23 R11.htm IDEA: XBRL DOCUMENT v3.8.0.1
EARNINGS PER SHARE
9 Months Ended
Sep. 30, 2017
Earnings Per Share [Abstract]  
EARNINGS PER SHARE

4. EARNINGS PER SHARE

The numerator for both basic and diluted earnings per share (EPS) is either net income, income from continuing operations, or income from discontinued operations. The denominator for basic EPS is the weighted-average number of common shares outstanding during the period. The dilutive effect of outstanding stock options, restricted stock units (RSUs) and performance share units (PSUs) is reflected in the denominator for diluted EPS using the treasury stock method.

The following table is a reconciliation of basic shares to diluted shares.

 

 

 

Three months ended

 

 

Nine months ended

 

 

 

September 30,

 

 

September 30,

 

(in millions)

 

2017

 

 

2016

 

 

2017

 

 

2016

 

Basic shares

 

 

545

 

 

 

544

 

 

 

543

 

 

 

547

 

Effect of dilutive securities

 

 

12

 

 

 

7

 

 

 

11

 

 

 

5

 

Diluted shares

 

 

557

 

 

 

551

 

 

 

554

 

 

 

552

 

 

The effect of dilutive securities included unexercised stock options, unvested RSUs and contingently issuable shares related to granted PSUs. The computation of diluted EPS excluded 0.1 million and 2.8 million of equity awards for the third quarter and nine months ended September 30, 2017, respectively, and 0.3 million and 10 million of equity awards for the third quarter and nine months ended September 30, 2016, respectively, because their inclusion would have had an anti-dilutive effect on diluted EPS. Refer to Note 9 for additional information regarding items impacting basic shares.

Stock repurchases

In July 2012, the Board of Directors authorized the repurchase of up to $2 billion of the company’s common stock. The board of directors increased this authority by an additional $1.5 billion in November 2016. During the first three quarters of 2017, the company repurchased 4.7 million shares for $275 million in cash. The company has $1.4 billion remaining available under the authorization as of September 30, 2017.